ORIGINAL RESEARCH
Published on 02 May 2025
Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination
doi 10.3389/fimmu.2025.1579163
- 442 views
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Vaccines and Breakthrough Infections
Vaccines and Breakthrough Infections
1,407
Total downloads
8,405
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Accepted on 23 Apr 2025
Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy
doi 10.3389/fimmu.2025.1569151
- 193 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Isolation of human monoclonal antibodies from 4CMenB vaccinees reveals PorB and LOS as the main OMV components inducing cross-strain protection
doi 10.3389/fimmu.2025.1565862
- 960 views
PERSPECTIVE
Published on 03 Apr 2025
Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network
doi 10.3389/fimmu.2025.1569251
- 587 views
ORIGINAL RESEARCH
Published on 27 Mar 2025
Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar
doi 10.3389/fimmu.2025.1557426
- 950 views
ORIGINAL RESEARCH
Published on 20 Mar 2025
Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens
doi 10.3389/fimmu.2025.1539492
- 2,259 views
REVIEW
Published on 05 Mar 2025
Opportunities and challenges of mRNA technologies in development of dengue virus vaccine
doi 10.3389/fimmu.2025.1520968
- 1,051 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.